163 related articles for article (PubMed ID: 35790324)
1. Multibacillary leprosy with an incubation period exceeding 50 years.
Taggart M; Kelly A; Stell R; Chu E
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35790324
[TBL] [Abstract][Full Text] [Related]
2. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Craig J; MacRae C; Melvin RG; Boggild AK
Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
[TBL] [Abstract][Full Text] [Related]
3. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
Soares DJ; Neupane K; Britton WJ
Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
[TBL] [Abstract][Full Text] [Related]
4. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Ozturk Z; Tatliparmak A
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: A prospective observational study from Northern India.
Singh I; Ahuja M; Lavania M; Pathak VK; Turankar RP; Singh V; Sengupta U; Das L; Kumar A; Saini GB
Indian J Dermatol Venereol Leprol; 2023; 89(2):226-232. PubMed ID: 36331863
[TBL] [Abstract][Full Text] [Related]
6. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
[TBL] [Abstract][Full Text] [Related]
7. Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy.
Gunawan H; Sasmojo M; Putri HE; Avriyanti E; Hindritiani R; Suwarsa O
Int J Mycobacteriol; 2018; 7(2):152-155. PubMed ID: 29900892
[TBL] [Abstract][Full Text] [Related]
8. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature.
Trindade MA; Palermo ML; Pagliari C; Valente N; Naafs B; Massarollo PC; D'Albuquerque LA; Benard G
Transpl Infect Dis; 2011 Feb; 13(1):63-9. PubMed ID: 20678090
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and interactions of antileprosy drugs.
George J
Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
[TBL] [Abstract][Full Text] [Related]
10. Advances in the diagnosis and treatment of leprosy.
Katoch VM
Expert Rev Mol Med; 2002 Jul; 4(15):1-14. PubMed ID: 14585155
[TBL] [Abstract][Full Text] [Related]
11. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
Penna GO; Pontes MAA; Talhari S; Gonçalves HS; Talhari C; Pessoa AS; Pedroza V; Bührer-Sékula S; Stefani MMA; Penna MLF
Braz J Infect Dis; 2024; 28(2):103745. PubMed ID: 38697216
[TBL] [Abstract][Full Text] [Related]
12.
Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
Front Immunol; 2018; 9():915. PubMed ID: 29867930
[TBL] [Abstract][Full Text] [Related]
13. Case for diagnosis. Infiltrated areas on the trunk.
Góes LDM; Scrignoli JA; Morais P; Talhari C
An Bras Dermatol; 2020; 95(5):652-654. PubMed ID: 32651045
[TBL] [Abstract][Full Text] [Related]
14. Multibacillary leprosy mimicking systemic lupus erythematosus: case report and literature review.
Horta-Baas G; Hernández-Cabrera MF; Barile-Fabris LA; Romero-Figueroa Mdel S; Arenas-Guzmán R
Lupus; 2015 Sep; 24(10):1095-102. PubMed ID: 25761657
[TBL] [Abstract][Full Text] [Related]
15. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
[TBL] [Abstract][Full Text] [Related]
16. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
17. Clinical-pathological conference: case 3.
Hall JM; Torske KR; Kahn MA; Moreland AA; Moschella SL
Head Neck Pathol; 2010 Sep; 4(3):226-9. PubMed ID: 20676829
[No Abstract] [Full Text] [Related]
18. Multidrug therapy for leprosy: a game changer on the path to elimination.
Smith CS; Aerts A; Saunderson P; Kawuma J; Kita E; Virmond M
Lancet Infect Dis; 2017 Sep; 17(9):e293-e297. PubMed ID: 28693853
[TBL] [Abstract][Full Text] [Related]
19. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Guerrero MI; Colorado CL; Torres JF; León CI
Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
[TBL] [Abstract][Full Text] [Related]
20. Update on the epidemiology, diagnosis, and treatment of leprosy.
Reibel F; Cambau E; Aubry A
Med Mal Infect; 2015 Sep; 45(9):383-93. PubMed ID: 26428602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]